Compare Agilent Technologies Inc (A) vs BlackRock TCP Capital Corp (TCPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs BlackRock TCP Capital Corp — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while BlackRock TCP Capital Corp trades at $3.9 (market cap $331.42M). The key difference: Agilent Technologies Inc is far larger — about 126.7× BlackRock TCP Capital Corp's market cap, and BlackRock TCP Capital Corp pays the higher dividend (19.24%). Which is the better fit depends on your goals.
| A | TCPC | |
|---|---|---|
Market Cap | $42.00B | $331.42M |
Sector | Health | Financials |
52-Week High | $157.20 | $7.26 |
52-Week Low | $110.24 | $3.13 |
Enterprise Value | $43.55B | — |
Dividend Yield | 0.69% | 19.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
TCPC trades at $4.11, up 5.38% in 24 hours, with a bullish technical signal from moving averages despite overbought RSI readings. The company reported Q2 2026 earnings of $0.22 per share, beating expectations, and announced a $523 million portfolio sale to reduce leverage. However, fundamentals show negative revenue and net income trends, with a net income margin of 118.75% reflecting significant losses relative to revenue.
The outlook is mixed: strategic actions like portfolio sales and dividend payments ($0.17 per share) support value, but persistent losses and class action lawsuits pose risks. Analyst consensus leans hold, with 30.77% buy ratings, indicating cautious optimism amid financial challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About BlackRock TCP Capital Corp
BlackRock TCP Capital Corp is a finance company specializing in middle-market lending. It aims for high returns through income and capital appreciation while prioritizing principal protection. The company invests in debt securities and earns revenue from interest payments, fees, and some equity appreciation.
Read more on TCPC →
